Real-life experience with benralizumab during 6 months
Abstract Background Benralizumab is a monoclonal antibody that binds to the human interleukin-5 (IL-5) receptor (IL-5R), thereby preventing IL-5 from binding to its receptor and inhibiting differentiation and maturation of eosinophils in the bone marrow. Because of its recent marketing approval, suf...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2020-06-01
|
| coleção: | BMC Pulmonary Medicine |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s12890-020-01220-9 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|